1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends

Epiomic Epidemiology Series: Stomach Cancer Forecast in 17 Major Markets 2016-2026

  • February 2016
  • 66 pages
  • Black Swan Analysis Ltd
Report ID: 3791836

Summary

Table of Contents

Search Inside

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Stomach Cancer in 17 Major Markets

Stomach cancer is a broad term encompassing tumours arising in the stomach and includes gastric carcinoma which is a malignant epithelial-origin tumour commonly developing after prolonged periods of gastritis. Stomach cancers tend to develop slowly over many years spreading in different ways. Long-term infection of the stomach with Helicobacter pylori may lead to inflammation (known as chronic atrophic gastritis) and pre-cancerous changes to the inner lining of the stomach.

This report provides the current incident population for Stomach Cancer across 17 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, India, Mexico, Turkey, Argentina, Australia, Canada, Russian, Saudi Arabia and South Africa) split by gender and 5-year age cohort. Along with the current incidence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the classifications and co-morbidities of Stomach Cancer have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main features and co-morbidities associated with Stomach Cancer include:

-History of stomach polyps or stomach lymphoma
-Family history of stomach cancer
-Colorectal cancer
-Familial adenomatous polyposis
-BRCA1/BRCA2 mutations
-Megaloblastic (pernicious) anaemia or being blood type A

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

-Able to quantify patient populations in global Stomach Cancer’s market to target the development of future products, pricing strategies and launch plans.
-Gain further insight into the incidence of the subdivided types of Stomach Cancer and identify patient segments with high potential.
-Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
-Provide a level of understanding on the impact from specific co-morbid conditions on Stomach Cancer’s incident population.
-Identify sub-populations within Stomach Cancer which require treatment.
-Gain an understanding of the specific markets that have the largest number of Stomach Cancer patients.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Epiomic Epidemiology Series: BRCA 1 & 2 Mutation in Cancer Forecast in 18 Major Markets 2017-2027

  • $ 6859
  • Industry report
  • June 2017
  • by Black Swan Analysis Ltd

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on BRCA1 and BRCA2 mutation in Cancer in 18 Major Markets It has long been established that BRCA1 and BRCA2 (BReast CAncer susceptibility ...

Epiomic Epidemiology Series: PD-L1 Overexpression in Solid Tumours Forecast in 18 Major Markets 2017-2027

  • $ 6859
  • Industry report
  • June 2017
  • by Black Swan Analysis Ltd

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on PDL-1 over-expression in Cancer in 18 Major Markets PD-1 is a T-cell immune checkpoint that is involved in the dampening of autoimmunity ...

Cancer Immunology and Oncolytic Virology: Technologies and Global Markets

  • $ 5501
  • Industry report
  • May 2017
  • by BCC Research

Highlights • The global cancer immunotherapy market should reach $96.5 billion by 2021 from $73.0 billion in 2016 at a compound annual growth rate (CAGR) of 5.7%, from 2016 to 2021. • The US region ...


Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in Canada

  • July 2017
    10 pages
  • Cancer  

  • Canada  

View report >

Cancer Statistics in Canada

  • July 2017
    26 pages
  • Cancer  

    Chronic Disease  

    Public Health  

  • Canada  

    North America  

View report >

Cancer Statistics in the US, Weekly Update

  • July 2017
    16 pages
  • Cancer  

  • United States  

View report >

Related Market Segments :

Stomach Cancer

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.